Our study has further shown a significant correlation of CYP24A1 expression with several clinical features, including the lesion site, general type, and histologic type of CRC, which confirms a pro-oncogenic effect of CYP24A1. The gene discussed is CYP24A1; the disease is colorectal carcinoma.